Center for Brain Immunology and Glia (BIG), Department of Neuroscience, University of Virginia, Charlottesville, VA, USA.
Neuroscience Graduate Program, University of Virginia, Charlottesville, VA, USA.
Eur J Immunol. 2023 Jun;53(6):e2250266. doi: 10.1002/eji.202250266. Epub 2023 May 4.
Tauopathies, which include frontotemporal dementia, Alzheimer's disease, and chronic traumatic encephalopathy, are a class of neurological disorders resulting from pathogenic tau aggregates. These aggregates disrupt neuronal health and function leading to the cognitive and physical decline of tauopathy patients. Genome-wide association studies and clinical evidence have brought to light the large role of the immune system in inducing and driving tau-mediated pathology. More specifically, innate immune genes are found to harbor tauopathy risk alleles, and innate immune pathways are upregulated throughout the course of disease. Experimental evidence has expanded on these findings by describing pivotal roles for the innate immune system in the regulation of tau kinases and tau aggregates. In this review, we summarize the literature implicating innate immune pathways as drivers of tauopathy.
tau 病包括额颞叶痴呆、阿尔茨海默病和慢性创伤性脑病,是一类由致病性 tau 聚集物引起的神经退行性疾病。这些聚集物破坏神经元的健康和功能,导致 tau 病患者的认知和身体功能下降。全基因组关联研究和临床证据表明,免疫系统在诱导和驱动 tau 介导的病理方面起着重要作用。更具体地说,先天免疫基因被发现含有 tau 病风险等位基因,先天免疫途径在疾病过程中被上调。实验证据通过描述先天免疫系统在调节 tau 激酶和 tau 聚集物方面的关键作用扩展了这些发现。在这篇综述中,我们总结了将先天免疫途径作为 tau 病驱动因素的文献。